Incidence, clinical evaluation and antimicrobial susceptibility pattern of bacteria isolated from diabetic patients

Diabetes mellitus (DM) is classified as an endocrinological disorder of metabolism, which is marked by an increased rise in prevalence as well as incidence around the globe. The main aim of the study includes an assessment of the incidence, clinical profile evaluation and susceptibility pattern of bacteria against antimicrobial drugs in diabetic subjects. A total of 280 cases were included in the study of which the patients diagnosed with diabetes were assessed for their biochemical profiles as well as culture and sensitivity assays. 106 patients were diagnosed with diabetes out of 280 and were also associated with certain physiological disorders. Among these 106 patients, 103 patients showed an incidence of microbial infections. Of these patients, 63 were males, and 40 were females. Significant activities were observed against Klebsiella by tazobactam (68.8%). Sulzone (cefoperozone + sulbactam) demonstrated the most significant antimicrobial activities against Staphylococcus aureus (87.5%). Efficacy of Cefipime against Pseudomonas was quite substantial (66.6%) followed by Sulphamethazole (61.1%). Maximum activities were observed by cefixime against E. coli (61.5%) followed by nitrofurantoin (43.5%). Infections caused by Pseudomonas and Staphylococcus aureus were present in 18 and 8 patients, respectively.